Back
NovaBay Pharmaceuticals Quote, Financials, Valuation and Earnings
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
NBY
NovaBay Pharmaceuticals
Last Price:
0.57
Seasonality Move:
-6.61%
7 Day Trial
ALL ACCESS PASS
$
7
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.NovaBay Pharmaceuticals Price Quote
$0.57
-0.03 (-5.17%)
(Updated: December 3, 2024 at 2:20 PM ET)
NovaBay Pharmaceuticals Key Stats
Sell
19
NovaBay Pharmaceuticals (NBY)
is a Sell
Day range:
$0.58 - $0.61
52-week range:
$0.36 - $10.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.06
P/B ratio:
2.76%
Volume:
48.8K
Avg. volume:
796.4K
1-year change:
-94.4%
Market cap:
$2.9M
Revenue:
$14.7M
EPS:
$-35.8
How Much Does NovaBay Pharmaceuticals Make?
-
How Much Are NovaBay Pharmaceuticals's Sales Annually?
NBY Revenues are $14.7M -
How Much Profit Does NovaBay Pharmaceuticals's Make A Year?
NBY net income is -$9.6M
Is NovaBay Pharmaceuticals Growing As A Company?
-
What Is NovaBay Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.02% -
What Is NovaBay Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
NovaBay Pharmaceuticals Stock Price Performance
-
Did NovaBay Pharmaceuticals Stock Go Up Last Month?
NovaBay Pharmaceuticals share price went down by -19.85% last month -
Did NBY's Share Price Rise Over The Last Year?
NBY share price fell by -94.4% over the past 1 year
What Is NovaBay Pharmaceuticals 52-Week High & Low?
-
What Is NovaBay Pharmaceuticals’s 52-Week High Share Price?
NovaBay Pharmaceuticals has traded as high as $10.73 over the past 52 weeks -
What Is NovaBay Pharmaceuticals’s 52-Week Low Share Price?
NovaBay Pharmaceuticals has traded as low as $0.36 over the past 52 weeks
NovaBay Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy NovaBay Pharmaceuticals?
-
How Much Debt Does NovaBay Pharmaceuticals Have?
Total long term debt quarterly is $51K -
How Much Cash Does NovaBay Pharmaceuticals Have?
Cash and short term investments quarterly total is $776K -
What Is NovaBay Pharmaceuticals’s Book Value Per Share?
Book value per share is 0.22
Is NovaBay Pharmaceuticals Cash Flow Positive?
-
What Is NBY Cash Flow From Operations?
Cash flow from operations (TTM) is -$4.8M -
What Is NovaBay Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $974K -
What Is NovaBay Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $1.1M
NovaBay Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
NBY return on invested capital is -334.47% -
What Is NovaBay Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -144.37% -
What Is NBY Return On Equity?
ROE is a measure of profitability and is -461.38%
NovaBay Pharmaceuticals Earnings Date & Stock Price
-
What Is NovaBay Pharmaceuticals's Stock Price Today?
A single share of NBY can be purchased today for 0.60 -
What Is NovaBay Pharmaceuticals’s Stock Symbol?
NovaBay Pharmaceuticals trades on the nyam under the ticker symbol: NBY -
When Is NovaBay Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for NovaBay Pharmaceuticals is scheduled on December 3, 2024 -
When Is NBY's next ex-dividend date?
NovaBay Pharmaceuticals's next ex-dividend date is December 3, 2024 -
How To Buy NovaBay Pharmaceuticals Stock?
You can buy NovaBay Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
NovaBay Pharmaceuticals Competitors
-
Who Are NovaBay Pharmaceuticals's Competitors?
Below is a list of companies who compete with NovaBay Pharmaceuticals or are related in some way:
NovaBay Pharmaceuticals Dividend Yield
-
What Is NBY Dividend Yield?
NovaBay Pharmaceuticals’s dividend yield currently is 0% -
What Is NovaBay Pharmaceuticals’s Payout Ratio?
NovaBay Pharmaceuticals’s payout ratio is 0% -
When Did NovaBay Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is December 3, 2024 -
What Is NovaBay Pharmaceuticals’s Dividend Per Share?
NovaBay Pharmaceuticals pays a dividend of $0.00 per share
NovaBay Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -94.78% |
| Revenue: | -1.61% | -7.01% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 3.73 |
| Upside from Last Price: | 519.7% |